Takeda Pharmaceuticals U.S.A., Inc. v. Alkem Laboratories Limited et al
Plaintiff: Takeda Pharmaceuticals U.S.A., Inc.
Defendant: Ascend Laboratories, LLC and Alkem Laboratories Limited
Case Number: 1:2020cv00325
Filed: March 3, 2020
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on April 17, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
April 17, 2020 Filing 41 REDACTED VERSION of #37 Sealed Exhibit A, by Alkem Laboratories Limited, Ascend Laboratories, LLC. (Wilson, Samantha) Modified on 4/17/2020 (nms).
April 17, 2020 REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #37 . (nms)
April 8, 2020 Filing 40 REDACTED VERSION of #32 Sealed Transcript. (nms)
April 8, 2020 Opinion or Order Filing 39 ORDER Granting #36 MOTION to Seal and Redact Transcript. Signed by Judge Richard G. Andrews on 4/8/2020. (nms)
April 7, 2020 Filing 38 DECLARATION of Samantha G. Wilson re #36 MOTION to Seal and Redact Transcript, by Alkem Laboratories Limited, Ascend Laboratories, LLC. (Wilson, Samantha) Modified on 4/8/2020 (nms).
April 7, 2020 Filing 37 [SEALED] EXHIBIT A re #36 MOTION to Seal and Redact Transcript, by Alkem Laboratories Limited, Ascend Laboratories, LLC. (Wilson, Samantha) Modified on 4/8/2020 (nms).
April 7, 2020 Filing 36 MOTION to Seal and Redact Transcript - filed by Alkem Laboratories Limited, Ascend Laboratories, LLC. (Attachments: #1 Exhibit B, #2 Proposed Order)(Wilson, Samantha) Modified on 4/8/2020 (nms).
March 24, 2020 Opinion or Order Filing 35 SO ORDERED, re #34 Stipulation to Stay Pending Appeal to the Federal Circuit. Signed by Judge Richard G. Andrews on 3/24/2020. (nms)
March 24, 2020 Filing 34 STIPULATION to Stay Pending Appeal to the Federal Circuit, by Alkem Laboratories Limited, Ascend Laboratories, LLC. (Wilson, Samantha) Modified on 3/24/2020 (nms).
March 23, 2020 Filing 33 NOTICE of Intent to Request Redaction by Samantha G. Wilson re #32 Transcript,, (Wilson, Samantha)
March 17, 2020 Filing 32 SEALED Official Transcript of Oral Argument held on 3/5/2020, before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov.. (Triozzi, Heather) Modified on 4/8/2020 (nms).
March 13, 2020 CORRECTING ENTRY: The redacted transcript filed at D.I. 23 has been removed from the docket. The Court Reporter will first file the sealed version of the transcript, and then the redacted version will be filed. (nms)
March 12, 2020 Filing 31 REDACTED VERSION of #8 Declaration, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 13)(DiGiovanni, Francis)
March 12, 2020 Filing 30 REDACTED VERSION of #7 Opening Brief in Support by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis)
March 12, 2020 Filing 29 REDACTED VERSION of #3 Complaint, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit A)(DiGiovanni, Francis)
March 12, 2020 Filing 28 NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re #21 Notice of Appeal (Federal Circuit), filed by Takeda Pharmaceuticals U.S.A., Inc.. USCA Case Number 2020-1545. (nms)
March 12, 2020 Opinion or Order Filing 27 SO ORDERED Granting #26 Stipulation and Order Allowing Defendants to Maintain Under Seal Their Opposition to Motion for a Temporary Restraining Order. Signed by Judge Richard G. Andrews on 3/12/2020. (nms)
March 11, 2020 Filing 26 STIPULATION Allowing Defendants to Maintain Under Seal Their Opposition to Plaintiff's Motion for Temporary Restraining Order by Alkem Laboratories Limited, Ascend Laboratories, LLC. (Wilson, Samantha)
March 11, 2020 Filing 25 REDACTED VERSION of #17 Memorandum in Opposition, by Alkem Laboratories Limited, Ascend Laboratories, LLC. (Wilson, Samantha) Modified on 3/12/2020 (nms).
March 10, 2020 Filing 24 Letter to The Honorable Richard G. Andrews from Samantha G. Wilson regarding the Court's March 5, 2020 Order - re #19 Order,. (Wilson, Samantha)
March 9, 2020 Filing 22 TRANSCRIPT REQUEST by Takeda Pharmaceuticals U.S.A., Inc. for proceedings held on March 5, 2020 before Judge Richard G. Andrews. (Rahmeier, Thatcher)
March 6, 2020 Filing 21 NOTICE OF APPEAL to the Federal Circuit of #19 Order, . Appeal filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis)
March 6, 2020 Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re #21 Notice of Appeal (Federal Circuit). (kmd)
March 6, 2020 Notification regarding #21 Notice of Appeal (Federal Circuit) sent to Reporter Triozzi. (kmd)
March 6, 2020 APPEAL - Credit Card Payment of $505.00 received re #21 Notice of Appeal (Federal Circuit) filed by Takeda Pharmaceuticals U.S.A., Inc.. ( Filing fee $505, receipt number 0311-2872299.) (DiGiovanni, Francis)
March 5, 2020 Opinion or Order Filing 20 ORDER Granting Motion for Confidential Treatment of Certain Filings (D.I. #1 ) (see Order for further details). Signed by Judge Richard G. Andrews on 3/5/2020. (nms)
March 5, 2020 Opinion or Order Filing 19 ORDER: The motion for a temporary restraining order and a preliminary injunction (D.I. #6 ) is DENIED. Defendants are ORDERED to maintain the status quo until the end of the day March 12, 2020 (see Order for further details). Signed by Judge Richard G. Andrews on 3/5/2020. (nms)
March 5, 2020 CORRECTING ENTRY: Exhibit 13 initially filed at D.I. #9 has been removed from that entry and added to the filing at D.I. #8 . Exhibit 13 is a sealed filing and therefore should not have been filed with publically viewable exhibits. (nms)
March 5, 2020 Pro Hac Vice Attorney Jonathan Herstoff,Edgar H. Haug,Porter F. Fleming for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak)
March 5, 2020 Pro Hac Vice Attorney Teresa M. Summers for Alkem Laboratories Limited,Teresa M. Summers for Ascend Laboratories, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
March 5, 2020 Minute Entry for proceedings held before Judge Richard G. Andrews - Motion Hearing held on 3/5/2020 re #6 MOTION for Temporary Restraining Order. Local counsel present for plaintiff: F. DiGiovanni. Local counsel present for defendants: S. Wilson. (Court Reporter Heather Triozzi.) (crb)
March 5, 2020 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
March 5, 2020 Opinion or Order SO ORDERED, re #18 MOTION for Pro Hac Vice Appearance of Attorney Lawrence M. Sung, Attorney Neal Seth and Attorney Teresa M. Summers, filed by Alkem Laboratories Limited, Ascend Laboratories, LLC. Signed by Judge Richard G. Andrews on 3/5/2020. (nms)
March 5, 2020 Opinion or Order SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Porter F. Fleming, and Jonathan Herstoff, filed by Takeda Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 3/5/2020. (nms)
March 4, 2020 Filing 18 MOTION for Pro Hac Vice Appearance of Attorney Lawrence M. Sung, Attorney Neal Seth and Attorney Teresa M. Summers - filed by Alkem Laboratories Limited, Ascend Laboratories, LLC. (Wilson, Samantha)
March 4, 2020 Filing 17 [SEALED] MEMORANDUM in Opposition re #6 MOTION for Temporary Restraining Order, filed by Alkem Laboratories Limited, Ascend Laboratories, LLC. Reply Brief due date per Local Rules is 3/11/2020. (Attachments: #1 Exhibits 1-2)(Wilson, Samantha) Modified on 3/5/2020 (nms).
March 4, 2020 Filing 16 NOTICE of Appearance by Samantha G. Wilson on behalf of All Defendants (Wilson, Samantha)
March 4, 2020 Filing 15 NOTICE of Appearance by Adam Wyatt Poff on behalf of All Defendants (Poff, Adam)
March 4, 2020 Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Edgar H. Haug, Porter F. Fleming, and Jonathan Herstoff - filed by Takeda Pharmaceuticals U.S.A., Inc.. (DiGiovanni, Francis)
March 4, 2020 Opinion or Order Filing 13 ORAL ORDER: Defendants are ordered to respond to Takedas request for a TRO by COB today. There will be a hearing on the motion for TRO at 9:30 a.m. on Thursday, March 5, 2020, in Courtroom 4A before Judge Richard G. Andrews. Takeda is ordered to give Defendants immediate notice of this Order. Ordered by Judge Richard G. Andrews on 3/4/2020. (nms)
March 4, 2020 Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Limited on 3/4/2020; Ascend Laboratories, LLC on 3/4/2020. (kmd)
March 3, 2020 Remark: Duty matter submitted to duty judge (LPS). (amf)
March 3, 2020 Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited for Takeda Pharmaceuticals U.S.A., Inc. - filed by Takeda Pharmaceuticals U.S.A., Inc. (amf)
March 3, 2020 Filing 11 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) SEE ATTACHED LISTS. (Attachments: #1 Patent/Trademark Report continued)(amf)
March 3, 2020 Filing 10 DECLARATION of Mark J. Buonaiuto re #6 MOTION for Temporary Restraining Order by Takeda Pharmaceuticals U.S.A., Inc.. (amf)
March 3, 2020 Filing 9 EXHIBIT to D.I. #8 Declaration of Porter F. Fleming in Support of D.I. #6 Motion for Temporary Restraining Order and Preliminary Injucntion - filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: #1 Exhibit 3, #2 Exhibit 4, #3 Exhibit 5, #4 Exhibit 6, #5 Exhibit 8, #6 Exhibit 9, #7 Exhibit 10, #8 Exhibit 11, #9 Exhibit 12, #11 Exhibit 14)(amf) Modified on 3/3/2020 (amf). Modified on 3/5/2020 (nms).
March 3, 2020 Filing 8 [SEALED] DECLARATION of Porter F. Fleming re D.I. #6 MOTION for Temporary Restraining Order and Preliminary Injuction - filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 7)(amf) Modified on 3/3/2020 (amf). (Additional attachment(s) added on 3/5/2020: #3 Exhibit 13) (nms).
March 3, 2020 Filing 7 [SEALED] OPENING BRIEF in Support re #6 MOTION for Temporary Restraining Order and Preliminary Injunction - filed by Takeda Pharmaceuticals U.S.A., Inc.Answering Brief/Response due date per Local Rules is 3/17/2020. (amf)
March 3, 2020 Filing 6 MOTION for Temporary Restraining Order and a Preliminary Injuction - filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(amf)
March 3, 2020 Filing 5 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf)
March 3, 2020 Filing 4 EXHIBITS to #3 Complaint, by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: #1 Exhibit C, #2 Exhibit D, #3 Exhibit E, #4 Exhibit F, #5 Exhibit G, #6 Exhibit H, #7 Exhibit I, #8 Exhibit J, #9 Exhibit K, #10 Exhibit L, #11 Exhibit M, #12 Exhibit N, #13 Exhibit O, #14 Exhibit P, #15 Exhibit Q, #16 Exhibit R, #17 Exhibit S, #18 Exhibit T, #19 Exhibit U, #20 Exhibit V, #21 Exhibit W, #22 Exhibit X, #23 Exhibit Y, #24 Exhibit Z, #25 Exhibit AA, #26 Exhibit BB)(amf) Modified on 3/5/2020 (nms).
March 3, 2020 Filing 3 [SEALED] COMPLAINT filed with Jury Demand against Alkem Laboratories Limited AND Ascend Laboratories, LLC - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number DEX033521) - filed by Takeda Pharmaceuticals U.S.A., Inc. (Attachments: #1 Exhibit A)(amf)
March 3, 2020 Filing 2 DECLARATION of Thatcher A. Rahmeier re #1 MOTION to Seal, filed by Takeda Pharmaceuticals U.S.A., Inc. (amf) Modified on 3/5/2020 (nms).
March 3, 2020 Filing 1 MOTION to Seal Complaint, Opening Brief in Support of Motion for Temporary Restraining Order, and Declaration in Support of Motion for Temporary Restraining Order - filed by Takeda Pharmaceuticals U.S.A., Inc. (amf)
March 3, 2020 No Summons Issued. (amf)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Takeda Pharmaceuticals U.S.A., Inc. v. Alkem Laboratories Limited et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ascend Laboratories, LLC
Represented By: Samantha G. Wilson
Represented By: Teresa M. Summers
Represented By: Adam Wyatt Poff
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Alkem Laboratories Limited
Represented By: Samantha G. Wilson
Represented By: Teresa M. Summers
Represented By: Adam Wyatt Poff
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Takeda Pharmaceuticals U.S.A., Inc.
Represented By: Thatcher A. Rahmeier
Represented By: Francis DiGiovanni
Represented By: Edgar H. Haug
Represented By: Porter F. Fleming
Represented By: Jonathan Herstoff
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?